Whipple's disease medical therapy

Whipple's disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Whipple's disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Whipple's disease medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Whipple's disease medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Whipple's disease medical therapy
CDC on Whipple's disease medical therapy
Whipple's disease medical therapy in the news
Blogs on Whipple's disease medical therapy
Directions to Hospitals Treating Whipple's disease
Risk calculators and risk factors for Whipple's disease medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Overview

The mainstay of treatment for Whipple's disease is systemic long-term antibiotic therapy. Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].

Medical Therapy

• Pharmacologic medical therapy for Whipple's disease includes long-term antibiotics.

Disease Name

• Classic Whipple's disease
  • Initial therapy
    • Preferred regimen (1): drug name 100 mg PO q12h for 10-21 days (Contraindications/specific instructions)
    • Preferred regimen (2): drug name 500 mg PO q8h for 14-21 days
    • Alternative regimen (1): drug name 500 mg PO q6h for 7–10 days
  • Maintenance therapy
    • Preferred regimen (1): drug name 100 mg PO q12h for 10-21 days (Contraindications/specific instructions)
    • Alternative regimen (1): drug name 500 mg PO q6h for 7–10 days

• CNS infection
  • Initial therapy
    • • Preferred regimen (1): drug name 100 mg PO q12h for 10-21 days (Contraindications/specific instructions)
      • Preferred regimen (2): drug name 500 mg PO q8h for 14-21 days
      • Alternative regimen (1): drug name 500 mg PO q6h for 7–10 days
  • Maintenance therapy
    • Preferred regimen (1): drug name 100 mg PO q12h for 10-21 days (Contraindications/specific instructions)
    • Alternative regimen (1): drug name 500 mg PO q6h for 7–10 days

• Endocarditis
  • Initial therapy
    • • Preferred regimen (1): drug name 100 mg PO q12h for 10-21 days (Contraindications/specific instructions)
      • Preferred regimen (2): drug name 500 mg PO q8h for 14-21 days
      • Alternative regimen (1): drug name 500 mg PO q6h for 7–10 days
  • Maintenance therapy
    • Preferred regimen (1): drug name 100 mg PO q12h for 10-21 days (Contraindications/specific instructions)
    • Alternative regimen (1): drug name 500 mg PO q6h for 7–10 days

• Relapse
  • Initial therapy
    • • Preferred regimen (1): drug name 100 mg PO q12h for 10-21 days (Contraindications/specific instructions)
      • Preferred regimen (2): drug name 500 mg PO q8h for 14-21 days
      • Alternative regimen (1): drug name 500 mg PO q6h for 7–10 days
  • Maintenance therapy
    • Preferred regimen (1): drug name 100 mg PO q12h for 10-21 days (Contraindications/specific instructions)
    • Alternative regimen (1): drug name 500 mg PO q6h for 7–10 days

• 1. Initial Parenteral Therapy

• Preferred regimen: Ceftriaxone 2 g IV daily for 2 weeks

• 2. Long-term Therapy

• Preferred regimen: Trimethoprim-sulfamethoxazole 160/800 mg PO bid for at least 1 year
• Alternative regimen: Doxycycline 100 mg PO bid AND Hydroxychloroquine 200 mg PO tid in cases of allergy or relapse.

References

Template:WS Template:WH